Developmental Activities:

Non-Human Clinical Studies

  • cGMP fill and finish operations for pre-filled syringes and auto-injector systems
  • Chemistry and Manufacturing Control (CMC) sections of a Drug Application
  • Identification and qualification of suppliers of device components and assemblies
  • drug solution excipients and active pharmaceutical ingredients (API)
  • Formulation development
  • Container closure system manufacturers in the selection of drug contact materials
  • ICH shelf-life studies
  • Assay method and specifications for API, excipients and final drug product
  • Identification of drug impurities
  • Toxicology studies per FDA Guidelines

MSA News

Internship Experience Reflection – Kaitlyn Wylie

I never thought my first job would be in the biotechnology and pharmacy industry, let alone with such a passionate…

Read More

MesaGreen Pharmaceutical Company Files an Investigational New Animal Drug Application

FREDERICK, MD.  Nov. 10, 2022—MesaGreen Pharmaceutical Company announced today that the company has filed an Investigational New Animal Drug (INAD)…

Read More

Mesa Science Associates Receives Grant to Begin Study of a Treatment for Marfan Syndrome

Mesa Science Associates Inc. (MSA) received a Phase I Small Business Innovative Research Grant (SBIR) from the National Institutes of…

Read More